• OPEN AN ACCOUNT
Indian Indices
Nifty
24,924.70 916.70
(3.82%)
Sensex
81,641.96 -787.94
( -0.96%)
Bank Nifty
55,382.85 1,787.60
( 3.34%)
Nifty IT
38,282.55 2,402.45
( 6.70%)
Global Indices
Nasdaq
42,424.12 1,153.74
(2.80%)
Dow Jones
5,865.06 184.15
(3.24%)
Hang Seng
37,650.80 147.47
(0.39%)
Nikkei 225
8,604.98 50.18
(0.59%)
Forex
USD-INR
85.41 0.03
(0.03%)
EUR-INR
96.03 -0.26
(-0.27%)
GBP-INR
113.57 0.08
(0.07%)
JPY-INR
0.59 0.00
(-0.40%)

EQUITY - MARKET SCREENER

Sigachi Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543389
INE0D0K01022
13.4454797
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SIGACHI
27.16
1421.82
EPS(TTM)
Face Value()
Div & Yield %
1.57
1
0.23
 

Trimax Biosciences achieves EDQM Certificate of Suitability for Metformin Hydrochloride
May 07,2025
Sigachi Industries announced that Trimax Biosciences, a Sigachi Group Company has successfully achieved the Certificate of Suitability (CEP) for “Metformin Hydrochloride” from European Directorate for the Quality of Medicines & Health Care (EDQM). This milestone paves the way for Trimax to export this crucial Active Pharmaceutical Ingredient (API) to Europe and other CEP-accepting markets, further strengthening Sigachi's presence in highly regulated pharmaceutical markets.